Company / FCF Margin
Biogen FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
20.7%
FY2025
5-year range
11.3% / 30.8%
FY2021-FY2025
Trend
-26.3%
vs FY2024
Sector context
#28 of 131
Health Care
What the data says
Biogen's fcf margin of 20.7% is higher than 79% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 10 years, ranging from 11.3% in FY2022 to 45.6% in FY2019.
Based on SEC 10-K filings.
20.7% in FY2025 with a 5-year CAGR of -7.6%. Top quartile in the Health Care sector.
Improved from 12.9% to 20.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +9.5pp
- 5-Year Change
- -7.6pp
- 10-Year Change
- -
Sector benchmark
Top 21% in Health CareTop 21% of 131This company 20.7% Sector average -646.9%
▼
+103.2% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 26.3% year-over-year.
- Currently 667.7pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 20.7% | -26.3% |
| FY2024 | 28.1% | +117.9% |
| FY2023 | 12.9% | +14.8% |
| FY2022 | 11.3% | -63.5% |
| FY2021 | 30.8% | +8.8% |
| FY2020 | 28.3% | -38.0% |
| FY2019 | 45.6% | +13.4% |
| FY2018 | 40.3% | +34.2% |
| FY2017 | 30.0% | -13.5% |
| FY2016 | 34.7% | +14.0% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026